| Title | Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation |
| Authors | Liu, Hongling He, Xi Wang, Yudong Zhou, Shuangnan Zhang, Dali Zhu, Jiye He, Qiang Zhu, Zhijun Li, Guangming Sun, Libo Wang, Jianli Cheng, Gregory Liu, Zhenwen Lau, George |
| Affiliation | Chinese Peoples Liberat Army Gen Hosp, Liver Transplantat Ctr, Med Ctr 5, 100 West 4th Ring Middle Rd, Beijing 100039, Peoples R China Humanity & Hlth Clin Trial Ctr, Humanity & Hlth Med Grp, Unit 2101,21F,9 Queens Rd, Hong Kong, Peoples R China Beijing Med Univ, Peoples Hosp, Dept Surg, Beijing 100044, Peoples R China Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary & Pancreaticosplen Surg, Beijing 100020, Peoples R China Capital Med Univ, Beijing Friendship Hosp, Clin Ctr Pediat Liver Transplantat, Beijing 100050, Peoples R China Capital Med Univ, Beijing Youan Hosp, Dept Gen Surg, Beijing 100069, Peoples R China Capital Med Univ, Beijing Youan Hosp, Liver Transplant Ctr, Beijing 100069, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Dept Liver Transplantat, Med Ctr 3, Beijing 100039, Peoples R China |
| Keywords | ACUTE RESPIRATORY SYNDROME |
| Issue Date | Jul-2020 |
| Publisher | HEPATOLOGY INTERNATIONAL |
| Abstract | Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic. |
| URI | http://hdl.handle.net/20.500.11897/590356 |
| ISSN | 1936-0533 |
| DOI | 10.1007/s12072-020-10043-z |
| Indexed | SCI(E) |
| Appears in Collections: | 待认领 |
